Mylan to divest 11 injectables for Agila FTC clearance
This article was originally published in Scrip
Executive Summary
Mylan will need to divest 11 generic injectables to secure approval from the Federal Trade Commission (FTC) for its $1.6bn-plus acquisition of India's Agila Specialties.